Physician profile
Taylor Clark
NPI 1235657545
$1,955.52
in general payments reported to CMS, 2019-2025
16 companies · $1,633 in 2025
The $1,633 reported for 2025 was more than what 91% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $18.66 · 2023: $34.44 · 2024: $269 · 2025: $1,633.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,240 · Travel and Lodging: $697.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,239.99 |
| Travel and Lodging | $696.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $988.67 | 2025 | Vns Therapy |
| Abbvie INC. | $208.20 | 2025 | |
| Sk Life Science, INC. | $178.39 | 2025 | |
| Phathom Pharmaceuticals, INC. | $129.38 | 2024 | Voquezna |
| Biogen, INC. | $90.42 | 2025 | Vumerity, Tysabri, Qalsody |
| Ucb, INC. | $59.15 | 2024-2025 | Briviact, Fintepla |
| Orthofix Medical, INC. | $50.37 | 2024-2025 | Cervical-Stim, Spinal-Stim |
| Alexion Pharmaceuticals, INC. | $45.79 | 2024-2025 | Ultomiris |
| Sumitomo Pharma America, INC. | $34.19 | 2025 | Myfembree |
| Neurelis, INC. | $32.38 | 2022-2025 | Valtoco |
| Genentech USA, INC. | $32.24 | 2024 | Ocrevus Zunovo |
| Catalyst Pharmaceuticals, INC. | $24.67 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $23.70 | 2024 | Exparel, Zilretta, Iovera |
| Jazz Pharmaceuticals INC. | $23.53 | 2025 | |
| Acadia Pharmaceuticals INC | $20.60 | 2023 | Nuplazid |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $13.84 | 2023 | Rezum Generator |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.